Article Text

PDF

BAS/BSCR poster abstract
BAS/BSCR17 Myocardial xanthine oxidase regulates basal inotropy in murine left ventricular myocytes
  1. X H Sun,
  2. Y H Zhang,
  3. B Casadei
  1. Department of Cardiovascular Medicine, University of Oxford, John Radcliffe Hospital, UK

Abstract

Xanthine oxidase (XO) is a major source of reactive oxygen species in the cardiovascular system. Enhanced XO activity in the failing myocardium has been associated with a reduction in inotropy; however, whether this association is causal remains to be established. To test this hypothesis, the effect of XO inhibition (oxypurinol, 100 μmol/l and allopurinol, 100 μmol/l) or activation (xanthine, 100 or 500 μmol/l) on cell shortening (3 Hz, 35°) was evaluated in left ventricular (LV) myocytes isolated from C56BL/6–129j mice. Similarly, LV superoxide production in the absence and presence of inhibitors of XO, NADPH oxidases (apocynin, 100 μmol/l) or nitric oxide synthases (LNAME, 1 μmol/l) was measured by lucigenin (5 μmol/l)-enhanced chemiluminescence. Oxypurinol and allopurinol significantly suppressed basal superoxide production and cell shortening (by about 20%), whereas xanthine caused a dose-dependent increase in cell shortening and superoxide production. In contrast, apocynin had no effect on superoxide release or cell shortening. Taken together, our findings indicate that superoxide production by XO exerts a tonic positive inotropic effect on murine LV myocytes, suggesting that the increase in XO activity in heart failure may be, at least in part, adaptive.

    Statistics from Altmetric.com

      Request permissions

      If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.